LTFS
TWST icon

Ladenburg Thalmann Financial Services’s Twist Bioscience TWST Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-225
Closed -$7K – 5452
2019
Q2 		$7K Hold
225
– – ﹤0.01% 4588
2019
Q1 		$5K Hold
225
– – ﹤0.01% 4678
2018
Q4 		$5K Buy
+225
New +$4.99K ﹤0.01% 4616

Other funds holding TWST

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TWST Position: Q3 2019 in Review

Ladenburg Thalmann Financial Services sold out of Twist Bioscience (TWST) in Q3 2019, closing a stake of 225 shares — an estimated $7K sold.

Ladenburg Thalmann Financial Services first reported a position in TWST in Q4 2018 and held it in 3 quarters. The position peaked at $7K in Q2 2019. 84 funds tracked by Wall St. Rank hold TWST as of Q3 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Twist Bioscience position as of Q3 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 225 Twist Bioscience shares in Q3 2019, an estimated $7K.
  • Ladenburg Thalmann Financial Services first reported a position in Twist Bioscience in Q4 2018 and held it in 3 quarters.
  • Ladenburg Thalmann Financial Services's Twist Bioscience position peaked at $7K in Q2 2019.
  • 84 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.